Continuous Care
&
Active Supervision Policy

Continuous Care & Active Supervision Policy

For TRT Australia Pty Ltd


TL;DR – Important

If your subscription becomes more than 14 days overdue, you are no longer considered under the clinical supervision of TRT Australia or any doctor engaged by TRT Australia. At that point, your prescription token must be cancelled (disabled) and the pharmacy will be notified that the therapeutic relationship has ended. No medication can be dispensed until supervision is re-established and a new prescription is issued. A $200 AUD Re-Establishment & Prescription Review Fee applies to re-establish care and issue a new prescription token.

IMPORTANT: Active clients who maintain continuous care will NEVER pay prescription renewal fees. There are no hidden fees. The $200 AUD Re-Establishment & Prescription Review Fee ONLY applies if you allow your subscription to lapse beyond 14 days and need to re-establish clinical supervision.


1. Purpose of This Policy

Testosterone is a Schedule 4 (prescription-only) medicine. Under Australian standards, therapy can
only continue if you remain under continuous medical supervision.

This policy ensures compliance with:

  • Endocrine Society of Australia (ESA) guidance
  • RACGP preventive care guidelines
  • Therapeutic Goods Administration (TGA) requirements
  • AHPRA Good Medical Practice guidelines
  • State & territory poisons legislation

Testosterone can only be prescribed & dispensed when an active therapeutic relationship exists.

2. Why Continuous Care Is Required

Australian clinical and legal frameworks require:

  • Ongoing medical supervision
  • Monitoring and review of safety and outcomes
  • Active prescriber responsibility

If supervision lapses, the prescription can no longer legally remain active.

3. What Continuous Care Means

You are under continuous care when:

Requirement Condition Met
Active clinical supervision You remain under the care of TRT Australia
Doctor retains responsibility A treating practitioner continues oversight
Governance remains intact Prescription remains valid in a supervised context
Eligibility for resupply Care has not lapsed

Continuous care = medical oversight, not just possession of medication.

4. What Is Not Continuous Care

Behaviour Why It’s Not Supervised Care
Using leftover medication after supervision lapses Unsupervised hormone use
Allowing the subscription to lapse to delay renewal Breaks the therapeutic relationship
Stockpiling or stretching supply to postpone review Avoids medical oversight
Only renewing when a refill is needed Medication-access model, not medical care

5. The 14-Day Rule

A 14-day grace period preserves care while allowing time to renew. After 14 days overdue, supervision
is considered lapsed and the clinic cannot legally remain responsible for treatment.

During the 14-day grace period:

  • You remain supervised
  • Reminder notices may be issued
  • Renewal keeps care continuous
  • The supervising relationship remains intact

6. Transition to Inactive Status

Once more than 14 days overdue:

  • You are no longer under clinical supervision
  • The doctor cannot legally remain responsible
  • No dispensing can occur

7. Why Stockpiling or Delayed Renewal Is Not Permitted

Delaying renewal to use leftover medication is considered bypassing supervision.
Testosterone is not a supply-only therapy — it requires oversight across the full treatment interval.

8. Returning to Care After Inactive Status

Once supervision has lapsed beyond 14 days, the original duty of care held by TRT Australia and its contracted doctors has ended.
To lawfully recommence treatment, a new supervising relationship must be re-established.

This requires a doctor to issue a new prescription, as the original prescription is no longer linked to active clinical oversight.
This is not a financial mechanism but a governance requirement: a prescriber cannot assume clinical responsibility for a patient
who is not under their care.

8.1 Re-Establishment & Prescription Review Fee

When returning to care after inactive status, a $200 AUD Re-Establishment & Prescription Review Fee applies.
This fee covers the clinical work required for a prescribing doctor to:

  • Review your medical history and current health status
  • Assess the appropriateness of resuming treatment
  • Re-establish the therapeutic relationship
  • Issue a new prescription token under current supervision

This fee is in addition to:

  • Your reactivated subscription fee
  • Any medication or resupply costs

Treatment can only resume once:

  1. The patient returns to active care status
  2. The Re-Establishment & Prescription Review Fee is paid
  3. A valid prescription is reissued under current supervision

    TRT Australia operates with complete fee transparency. We want to be absolutely clear:

    For Active Clients (Those Who Maintain Continuous Care):
    – NO prescription renewal fees – ever
    – NO re-establishment fees
    – NO hidden charges
    – Your only costs are your subscription and medication resupply
    – Your prescription remains valid indefinitely and is a part of your subscription while you maintain active care

8.2 Cost Comparison (Illustrative Only)

Client Status What You Pay Outcome
✅ Active client needing a routine medication resupply Medication resupply cost (no extra fees) Continuous care, no interruption. Your existing prescription remains valid.
❌ Inactive client (>14 days overdue) wishing to resume Reactivated subscription + medication resupply cost + $200 AUD Re-Establishment & Prescription Review Fee Care must be re-established and a new prescription issued before dispensing can occur.

Keeping your subscription active protects your health and your wallet. Letting care lapse creates delays,
requires a new prescription, and adds the $200 re-establishment cost on top of your subscription and medication.

9. Why Medication Cannot Be Dispensed While Inactive

Pharmacies may only dispense prescription medication when you are actively under medical care and the prescription
reflects a current therapeutic relationship. If inactive, the eScript token must be
cancelled (disabled) until supervision is restored and a new prescription is issued.

10. Practical Examples

Example Status
Renew on time or within 14 days ✅ Continuous care
Overdue but within 14 days ✅ Still supervised
Wait months and continue using leftover testosterone ❌ Supervision ended — new prescription required after re-establishing care

11. Plain English Summary

Testosterone therapy in Australia must remain supervised. A subscription that lapses beyond 14 days means the treating relationship
has ended, which legally and clinically requires the prescription token to be cancelled (disabled). No pharmacy can supply testosterone
in the absence of active medical supervision. Restarting care requires re-establishing the doctor–patient relationship, paying a
$200 AUD Re-Establishment & Prescription Review Fee, and issuing a new prescription.

12. Why This Policy Protects You

Ongoing supervision ensures correct dosing, safety monitoring, and blood work oversight. Testosterone therapy
requires active medical oversight, not set-and-forget treatment.

13. Alignment with Australian Medical Standards

  • ESA Clinical Guideline on Male Hypogonadism (ongoing monitoring and prescriber responsibility)
  • RACGP standards for continuing review and oversight
  • AHPRA Good Medical Practice (monitoring, follow-up, and review)
  • TGA and state Schedule 4 regulations

14. Australian Legal & Regulatory Framework

  • Therapeutic Goods Act 1989
  • SUSMP – Schedule 4 (Prescription Only)
  • NSW Poisons and Therapeutic Goods Act 1966 & equivalent laws in other jurisdictions
  • AHPRA duties for ongoing clinical oversight

Continuous care is a legal requirement. When supervision lapses, the prescription is no longer valid
and the token must be disabled until care is re-established.

15. Why Our Approach May Differ from Other Clinics

TRT Australia applies a higher governance standard to remain a compliant, long-term medical provider — not a casual
dispensing service.

16. Legacy Clause

This policy applies to all current and future patients.

17. Glossary

Supervising Clinic: The clinical entity responsible for oversight of treatment (TRT Australia).
Treating Practitioner: A registered Australian medical practitioner engaged by TRT Australia.
Inactive Client: Subscription >14 days overdue; prescription token must be cancelled (disabled) and dispensing cannot occur.